Technical Analysis for CVAC - CureVac N.V.

Grade Last Price % Change Price Change
F 52.37 -3.38% -1.83
CVAC closed down 3.38 percent on Tuesday, July 27, 2021, on 21 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Flat
Historical CVAC trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction -3.38%
Inside Day Range Contraction -3.38%
Wide Bands Range Expansion -3.38%
Wide Bands Range Expansion -3.32%
1,2,3 Retracement Bearish Bearish Swing Setup -4.92%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.92%
Narrow Range Bar Range Contraction -4.92%
NR7 Range Contraction -4.92%
Inside Day Range Contraction -4.92%
Older End-of-Day Signals for CVAC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support about 14 hours ago
60 Minute Opening Range Breakdown about 14 hours ago
Down 3% about 14 hours ago
Fell Below 10 DMA about 14 hours ago
Fell Below Previous Day's Low about 14 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


CureVac N.V. Description

CureVac B.V., a clinical-stage biopharmaceutical company, engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102 that is in a Phase I clinical trial for the treatment of various types of solid tumors; and CV7202, which is investigating in a Phase I clinical trial for vaccination against rabies. It is also advancing mRNA vaccine program against coronavirus (SARS-CoV-2), which is in Phase I clinical trial. The company has collaboration and license agreements with GlaxoSmithKline Biologicals SA, Genmab B.V., Boehringer Ingelheim GmbH, and Eli Lilly and Company; development and option agreements with Arcturus Therapeutics, Inc., Acuitas Therapeutics Inc., and CRISPR Therapeutics AG; and a development and intellectual property agreement with Tesla Grohmann Automation GmbH. CureVac B.V. was founded in 2000 and is headquartered in Tübingen, Germany.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Acid Solid Tumors Health Care Coronavirus Vaccination Pharmaceutical Companies CRISPR Rabies Sars Boehringer Ingelheim Arcturus Therapeutics Genmab

Is CVAC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 151.8
52 Week Low 36.15
Average Volume 1,359,411
200-Day Moving Average 89.06
50-Day Moving Average 81.18
20-Day Moving Average 57.49
10-Day Moving Average 52.36
Average True Range 4.26
ADX 30.4
+DI 20.48
-DI 39.44
Chandelier Exit (Long, 3 ATRs) 63.41
Chandelier Exit (Short, 3 ATRs) 61.12
Upper Bollinger Bands 70.48
Lower Bollinger Band 44.50
Percent B (%b) 0.3
BandWidth 45.19
MACD Line -7.19
MACD Signal Line -8.64
MACD Histogram 1.4543
Fundamentals Value
Market Cap 9.32 Billion
Num Shares 178 Million
Price-to-Sales 315.17
Price-to-Book 20.55
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 56.80
Resistance 3 (R3) 57.01 55.74 56.06
Resistance 2 (R2) 55.74 54.62 55.64 55.81
Resistance 1 (R1) 54.06 53.92 53.43 53.85 55.57
Pivot Point 52.79 52.79 52.48 52.69 52.79
Support 1 (S1) 51.11 51.67 50.48 50.90 49.17
Support 2 (S2) 49.84 50.97 49.74 48.93
Support 3 (S3) 48.16 49.84 48.68
Support 4 (S4) 47.95